| Fund Raise Limit | ₹700 CrBoard Approved |
|---|---|
| Market Cap | ₹4,291.68 CrMid-cap Healthcare |
| Revenue TTM | ₹1,081.24 CrAnnual Operating |
| Net Profit Growth | 30.41%YoY Quarterly |
| Deal value | ₹700 Cr |
| Share of market cap | 16.3% |
Key highlights
- Capital raise approved for an aggregate amount not exceeding ₹700 crore
- Funding to be raised via equity shares or other eligible securities
- Shareholder approval process initiated through a draft Postal Ballot Notice
- Proposal follows a preliminary board intimation dated February 2, 2026
- The board meeting concluded at 6:00 PM following a 90-minute session
What Is the Fund Raise?
Artemis Medicare Services is embarking on a significant capital raising exercise aimed at securing up to ₹700 crore. The board has authorized the issuance of equity shares or other eligible securities in accordance with the Companies Act, 2013, and SEBI ICDR Regulations. This fund-raising initiative is designed to target permitted investors under terms and conditions to be finalized by the board or its designated committee.
To move forward, the company is seeking approval from its members through a postal ballot, with the draft notice already considered and approved by the directors.
Strategic Rationale
The decision to raise ₹700 crore signals a major growth phase for the hospital chain, which currently operates with a market capitalization of approximately ₹4,291 crore. By strengthening its equity base, the company positions itself to fund large-scale clinical expansions and technological upgrades without over-leveraging the balance sheet. This capital is vital for scaling its specialized verticals, such as the Daffodils by Artemis maternal care centers and the Artemis Lite multi-specialty neighborhood hospitals, which require significant upfront investment to establish market presence.
Financial Context
- The company reported a trailing twelve-month (TTM) net profit of ₹103.62 crore on revenues of ₹1,081.24 crore.
- Artemis maintains a high Durability Score of 75, indicating a strong financial health profile.
- Operating profit margins for the most recent quarter stood at 18.48% with a net profit growth of 30.41% YoY.
- The stock is currently trading at a TTM P/E of 41.42, which is lower than its three-year average of 62.93.
- Promoter holding remains steady at 58.39% with zero shares pledged as of the latest reporting period.
Business and Industry Context
Operating in the healthcare facilities sector, Artemis Medicare Services competes in an environment characterized by rising demand for tertiary and quaternary care. The company’s flagship Gurugram facility serves as a hub for complex medical procedures, while its newer formats allow for deeper penetration into residential clusters. This fundraise aligns with broader industry trends where major healthcare providers are consolidating their presence and expanding bed capacities to capture a larger share of India's growing medical tourism and domestic healthcare insurance markets.
| Share price | ₹271.1 |
|---|---|
| Market capitalisation | ₹4,291.68 Cr |
| Revenue (annual) | ₹1,081.24 Cr |
| Net profit (annual) | ₹103.62 Cr |
| Revenue (latest quarter) | ₹279.23 Cr+2.52% vs previous quarter |
| Net profit (latest quarter) | ₹30.03 Cr+34.43% vs previous quarter |
| P/E (TTM) | 41.42×Sector 58.46× |
| Promoter holding | 58.39%0.00% QoQ |
| FII holding | 12.19%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by Artemis Medicare Services Ltd announcing board approval for a ₹700 crore fund raise via equity issuance. Market figures from a third-party data provider.
